Gene Therapy for DME

Clinical trial NCT06492876 · RECRUITING

Trial details

NCT number: NCT06492876
Sponsor: Frontera Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2023-11-15
Primary completion: 2024-11-15
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.